• Trending Topics:    
  • 2024 Election
  • Joe Biden
  • Donald Trump
  • Congress
  • Faith
  • Sports
  • Immigration
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines
No Result
View All Result
IJR
No Result
View All Result
Home News

US FDA, CDC Lift Pause on Johnson & Johnson COVID-19 Vaccine Use

Reuters by Reuters
April 24, 2021 at 7:30 am
in News
245 7
2
US FDA, CDC Lift Pause on Johnson & Johnson COVID-19 Vaccine Use

FILE PHOTO: Johnson & Johnson's coronavirus disease (COVID-19) vaccines are seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton/File Photo

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the U.S. should be lifted and use of the vaccine should resume, the FDA said on Friday.

(Reporting by Kanishka Singh in Bengaluru; Editing by Chris Reese)

Tags: Coronavirus Outbreak
[firefly_poll]

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Thanks for reading IJR

Create your free account or log in to continue reading

Please enter a valid email
Forgot password?

By providing your information, you are entitled to Independent Journal Review`s email news updates free of charge. You also agree to our Privacy Policy and newsletter email usage